(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THE ELYSIUM DEVICE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THE ELYSIUM DEVICE

ST13

US500000090572871

Class

10

Filing

90572871

Registration

7037740

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

04/25/2023

Trademark type

Word

Nice classes

10

Filing date

03/11/2021

Registration date

04/25/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/25/2023

Last transaction

04/25/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

05/06/2021

First use in commerce

01/15/2022

Drawing code

4

Owner type

03

Owner location

San Clemente, CA, US

Examiner

PERKINS, ELLEN J

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SK Global Trading Inc

Representatives

Jalissa Bauman Horne CopyMark Law Group LLC

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Photobiomodulation beds specially made for medical purposes and frames therefor sold together as a unit

Publications

History of USPTO decisions and trademark events.

39 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/25/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

04/25/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/21/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/20/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/18/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/18/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/16/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/12/2022

GNRT

NON-FINAL ACTION E-MAILED

11/12/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

11/12/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/15/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/14/2022

EX1G

SOU EXTENSION 1 GRANTED

10/14/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/14/2022

IUAF

USE AMENDMENT FILED

10/05/2022

EXT1

SOU EXTENSION 1 FILED

10/05/2022

EEXT

SOU TEAS EXTENSION RECEIVED

10/05/2022

EISU

TEAS STATEMENT OF USE RECEIVED

10/05/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/05/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/08/2022

PUBO

PUBLISHED FOR OPPOSITION

02/08/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/19/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/04/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/11/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/11/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

12/10/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/26/2021

GNSL

LETTER OF SUSPENSION E-MAILED

10/26/2021

CNSL

SUSPENSION LETTER WRITTEN

10/26/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/25/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/25/2021

ALIE

ASSIGNED TO LIE

10/20/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/14/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/13/2021

GNRT

NON-FINAL ACTION E-MAILED

10/13/2021

CNRT

NON-FINAL ACTION WRITTEN

10/13/2021

DOCK

ASSIGNED TO EXAMINER

10/06/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/10/2021

NWAP

NEW APPLICATION ENTERED

03/15/2021

Continuous trademark protection

Get notified about every new filing that threatens THE ELYSIUM DEVICE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.